CHICAGO — Disease sub-stage specific PET imaging effectively detected relapses in stage III melanoma, according to findings presented at the ASCO Annual Meeting.
Conferences
Findings support wider excision margins in melanoma
A surgical excision margin of 3 cm yielded significantly improved disease-specific survival but not OS in a cohort of patients with high-risk melanoma, according to findings presented at the ASCO Annual Meeting.
No Need for Lymph Node Dissection in Certain Melanoma Patients
Surgically removing lymph nodes does not improve survival for certain patients with melanoma. The results from the large phase III randomized Dermatologic Cooperative Oncology Group Trial (abstract LBA9002) were presented at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting held May 29 to June 2 in Chicago.
Melanoma, Pediatric Oncology, Lymphoma Dominate Research Presentations from NYU Langone Medical Center at ASCO 2015
NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center will have a high profile at the 51st Annual Meeting of the American Society for Clinical Oncology (ASCO), with researchers presenting close to 30 abstracts accepted for oral, poster and publication presentations.